Skip to main content
. 2023 Apr 20;10:1168628. doi: 10.3389/fmed.2023.1168628

Table 1.

Characteristics of survey respondents with and without long COVID condition (LCC).

Variable Respondents with COVID-19 N = 2466* No LCC symptoms N = 1,211 LCC symptoms N = 1,178 p
Gender (n, % female) 1,626 (65.9%) 782 (64.7%) 803 (68.2%) 0.07
Age, mean (SD) 39.5 (53.3) 35.6 (14.4) 37.9 (14.9) <0.001
Age group (n, %)
<19 200 (8.1%) 106 (8.8%) 83 (7.1%) <0.001
20–29 736 (29.8%) 401(33.2%) 315 (26.8%)
30–39 556 (22.5%) 274 (22.6%) 267 (22.7%)
40–49 478 (19.4%) 210 (17.3%) 257 (21.9%)
50–59 295 (12.0%) 133 (11.0%) 154 (13.1%)
60–69 130 (5.3%) 64 (5.3%) 60 (5.1%)
70+ 71 (2.9%) 21 (1.7%) 38 (3.2%)
COVID test (n, % yes) 2098 (85.0%) 999 (83.0%) 984 (84.2%) 0.43
COVID vaccines at the time of infection
0 926 (37.6%) 388 (32.1%) 470 (40.1%) <0.001
1 239 (9.7%) 114 (9.4%) 108 (9.2%)
2 622 (25.2%) 312 (25.8%) 255 (21.7%)
>=3 799 (32.4%) 393 (32.6%) 340 (29.0%)
Smoking
No 1741 (70.6%) 901 (75.3%) 792 (68.0%) <0.001
Former 452 (18.3%) 181 (15.1%) 256 (22.0%)
Yes 237 (9.6%) 114 (9.5%) 116 (10.0%)
Main health conditions at the time of COVID-19
None 1799 (73.0%) 957 (79.1%) 791 (67.1%) <0.001
Respiratory disorders 134 (5.4%) 39 (3.2%) 87 (7.4%) <0.001
Cardiovascular disorders 172 (7.0%) 75 (6.2%) 90 (7.6%) 0.16
Diabetes 77 (3.1%) 29 (2.4%) 47 (4.0%) 0.03
Obesity 111 (4.5%) 47 (3.9%) 62 (5.3%) 0.11
Other metabolic disorders 93 (3.8%) 32 (2.6%) 59 (49.3%) 0.01
Rheumatic/autoimmune disorders 27 (1.1%) 14 (1.2%) 12 (1.0%) 0.74
Mental health disorders 5 (0.2%) 1 (0.1%) 3 (0.3%) 0.30
Other 42 (1.7%) 15 (1.2%) 23 (2.0%)
Used oxygen during COVID-19, yes (%) 272 (11.0%) 72 (5.9%) 176 (14.9%) <0.001
Education (n, %)
High school or less 562 (22.8%) 272 (22.5%) 267 (22.7%) 0.24
Apprenticeship 329 (13.3%) 177 (14.6%) 142 (12.1%)
College/some university 71 (2.9%) 41 (3.4%) 29 (2.5%)
University degree 1,041 (42.2%) 501 (41.4%) 509 (43.2%)
Post-graduate degree 418 (17.0%) 196 (16.2%) 212 (18.0%)
Prefer not to answer 45 (1.8%) 24 (2.0%) 19 (1.6%)
Annual family income (n, %)
<$3,000 683 (27.7%) 329 (27.2%) 328 (27.8%) 0.62
$3,000–5,000 314 (12.7%) 147 (12.1%) 165 (14.0%)
$5,001–10,000 252 (10.2%) 124 (10.2%) 122 (10.4%)
≥$10,001 329 (13.3%) 169 (14.0%) 152 (12.9%)
Prefer not to answer 888 (36.0%) 442 (36.5%) 411 (34.9%)
*

Includes people who had COVID <3 months ago and responded “prefer not to answer” to the question about COVID symptoms ≥3 months (n = 77). Survey questions were not mandatory, and some participants did not provide a response to all questions. Other metabolic disorders = kidney, liver, thyroid problems, hyperlipidemias/hypercholesterolemia. Other = neurologic conditions, vertigo, cancer, gastric problems, etc.